Gynecologic Oncology Group: Carcinoma, Adenosquamous trials

The registry lists 16 Carcinoma, Adenosquamous studies with Gynecologic Oncology Group as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 1 4Phase 2 6Phase 3 3No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT01266460Phase 2Results posted
• Trebananib in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT01210222Phase 2Results posted
• Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00820898Phase 2Results posted
• ABI-007 in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00309959Phase 2Results posted
• Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical CancerTerminatedNCT00070317Not applicableResults posted
• Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the CervixCompletedNCT00064077Phase 3Results posted
• Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine CorpusCompletedNCT00064025Phase 2Results posted
• Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00006011Phase 3Results posted
• Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical CancerStatus unknownNCT01295502Phase 1
• Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
• Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial CancerCompletedNCT00575952Phase 1
• Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesCompletedNCT00460356
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNCT00104910Phase 1
• Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical CancerCompletedNCT00068549Phase 1
• Capecitabine in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00039442Phase 2
• Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and AnemiaCompletedNCT00017004Phase 3